Erythropoietin enhances Kupffer cell number and activity in the challenged liver

Erythropoietin (EPO) is the main hormone driving mammalian erythropoiesis, with activity mediated via the surface receptor, EPO-R, on erythroid progenitor cells. Recombinant human EPO is currently used clinically for the treatment of anemia in patients with end-stage renal disease, and in certain ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilboa, Dafna, Haim-Ohana, Yasmin, Deshet-Unger, Naamit, Ben-Califa, Nathalie, Hiram-Bab, Sahar, Reuveni, Debby, Zigmond, Ehud, Gassmann, Max, Gabet, Yankel, Varol, Chen, Neumann, Drorit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583293/
https://www.ncbi.nlm.nih.gov/pubmed/28871174
http://dx.doi.org/10.1038/s41598-017-11082-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583293/
https://www.ncbi.nlm.nih.gov/pubmed/28871174
http://dx.doi.org/10.1038/s41598-017-11082-7

Ejemplares similares